SPINOCEREBELLAR ATAXIA TYPE 6
Clinical trials for SPINOCEREBELLAR ATAXIA TYPE 6 explained in plain language.
Never miss a new study
Get alerted when new SPINOCEREBELLAR ATAXIA TYPE 6 trials appear
Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIA TYPE 6, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare brain disorder: phase 3 trial tests potential treatment
Disease control Not yet recruitingThis study aims to see if a medicine called N-Acetyl-L-Leucine (IB1001) is safe and can help improve movement, balance, and quality of life for people with rare genetic disorders caused by a CACNA1A gene mutation. About 60 participants, aged 4 and older, will take either the stud…
Matched conditions: SPINOCEREBELLAR ATAXIA TYPE 6
Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control
Last updated Apr 04, 2026 06:35 UTC
-
Experimental stem cell therapy offers hope for rare neurological disorder
Disease control Not yet recruitingThis study is testing whether stem cells from umbilical cords can help people with spinocerebellar ataxia, a rare genetic condition that affects movement and coordination. Researchers will give stem cell treatments to 45 patients and track their symptoms for a full year to see if…
Matched conditions: SPINOCEREBELLAR ATAXIA TYPE 6
Phase: PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Brain pacemaker trial offers hope for debilitating balance disease
Disease control Not yet recruitingThis study is testing a new 'adaptive' brain stimulation device for adults with spinocerebellar ataxia type 6 (SCA6), a rare genetic disorder that causes worsening problems with balance and coordination. Five participants will have a device surgically implanted in their brain to …
Matched conditions: SPINOCEREBELLAR ATAXIA TYPE 6
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC